Abstract

BackgroundDiabetic retinopathy (DR) affects 10–24% of patients with diabetes mellitus type 1 or 2 in the primary care (PC) sector. As early detection is crucial for treatment, deep learning screening methods in PC setting could potentially aid in an accurate and timely diagnosis.PurposeThe purpose of this meta-analysis was to determine the current state of knowledge regarding deep learning (DL) screening methods for DR in PC.Data sourcesA systematic literature search was conducted using Medline, Web of Science, and Scopus to identify suitable studies.Study selectionSuitable studies were selected by two researchers independently. Studies assessing DL methods and the suitability of these screening systems (diagnostic parameters such as sensitivity and specificity, information on datasets and setting) in PC were selected. Excluded were studies focusing on lesions, applying conventional diagnostic imaging tools, conducted in secondary or tertiary care, and all publication types other than original research studies on human subjects.Data extractionThe following data was extracted from included studies: authors, title, year of publication, objectives, participants, setting, type of intervention/method, reference standard, grading scale, outcome measures, dataset, risk of bias, and performance measures.Data synthesis and conclusionThe summed sensitivity of all included studies was 87% and specificity was 90%. Given a prevalence of DR of 10% in patients with DM Type 2 in PC, the negative predictive value is 98% while the positive predictive value is 49%.LimitationsSelected studies showed a high variation in sample size and quality and quantity of available data.

Highlights

  • The prevalence of diabetes mellitus (DM) type 1 and 2 is rising, with approximately 629 million people worldwide expected to be suffering from this disease by the year 2045

  • In primary care (PC), 24% of type 1 and 10% of type 2 DM patients are reportedly diagnosed with a Diabetic retinopathy (DR), while in secondary and tertiary care the reported prevalence is higher [3]

  • 10 studies were identified and included in the meta-analysis. Among these are studies with clinically tested devices with registration for PC as well as devices registered for PC that were tested on publicly available datasets, non-certified, clinically tested deep learning (DL) algorithms, and DL algorithms tested on publicly available datasets

Read more

Summary

Introduction

The prevalence of diabetes mellitus (DM) type 1 and 2 is rising, with approximately 629 million people worldwide expected to be suffering from this disease by the year 2045. It is defined as damage to the blood vessels of the eyes caused by high blood glucose levels. The prevalence of this complication in Germany ranges from 10% to 30%, depending on the health care sector. Diabetic retinopathy (DR) affects 10–24% of patients with diabetes mellitus type 1 or 2 in the primary care (PC) sector. Suitable studies were selected by two researchers independently. Studies assessing DL methods and the suitability of these screening systems (diagnostic parameters such as sensitivity and specificity, information on datasets and setting) in PC were selected. Excluded were studies focusing on lesions, applying conventional diagnostic imaging tools, conducted in secondary or tertiary care, and all publication types other than original research studies on human subjects

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call